» Articles » PMID: 16309464

Novel Effects of the Prototype Translocating Escherichia Coli, Strain C25 on Intestinal Epithelial Structure and Barrier Function

Overview
Journal Cell Microbiol
Publisher Wiley
Date 2005 Nov 29
PMID 16309464
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Intestinal bacteria play an etiologic role in triggering and perpetuating chronic inflammatory bowel disorders. However, the precise mechanisms whereby the gut microflora influences intestinal cell function remain undefined. Therefore, the effects of the non-pathogenic prototype translocating Escherichia coli, strain C25 on the barrier properties of human T84 and Madine-Darby canine kidney type 1 epithelial cells were examined. T-84 cells were also infected with commensal E. coil, strains F18 and HB101, and enterohaemorrhagic E. coli, serotype O157:H7. Strains F18 and HB101 had no effect on transepithelial electrical resistance (TER) of T84 monolayers. By contrast, epithelial cells infected with strain C25 displayed a time-dependent decrease in TER, preceded by an altered distribution of the cytoskeletal protein alpha-actinin, comparable to infection with E. coli O157:H7. E. coli C25 infection also led to activation of nuclear factor kappaB (NF-kappaB), interleukin-8 secretion and alterations in localization of claudin-1, but not zona occludens-1 or claudin-4, in T84 cells. There were adherent C25 bacteria on the intact apical surface of infected T84 cells, while mitochondria appeared swollen and vacuolated. These novel findings demonstrate the ability of a translocating commensal bacterium to adhere to and modulate intestinal epithelial barrier function and to induce morphological changes in a manner distinct from the known enteric pathogen, E. coli O157:H7.

Citing Articles

Microbiome-derived metabolite effects on intestinal barrier integrity and immune cell response to infection.

Adams L, Li X, Burchmore R, Goodwin R, Wall D Microbiology (Reading). 2024; 170(10).

PMID: 39392674 PMC: 11469068. DOI: 10.1099/mic.0.001504.


Deciphering internal and external factors influencing intestinal junctional complexes.

Markovich Z, Abreu A, Sheng Y, Han S, Xiao R Gut Microbes. 2024; 16(1):2389320.

PMID: 39150987 PMC: 11332634. DOI: 10.1080/19490976.2024.2389320.


Intestinal barrier functions in hematologic and oncologic diseases.

Haroun E, Ashok Kumar P, Saba L, Kassab J, Ghimire K, Dutta D J Transl Med. 2023; 21(1):233.

PMID: 37004099 PMC: 10064590. DOI: 10.1186/s12967-023-04091-w.


The role of lipopolysaccharides in diabetic retinopathy.

Qin X, Zou H BMC Ophthalmol. 2022; 22(1):86.

PMID: 35193549 PMC: 8862382. DOI: 10.1186/s12886-022-02296-z.


Corrigendum: Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier.

Barbara G, Barbaro M, Fuschi D, Palombo M, Falangone F, Cremon C Front Nutr. 2021; 8:790387.

PMID: 34790692 PMC: 8591313. DOI: 10.3389/fnut.2021.790387.